Glenmark’s Favipiravir Shows Promise for COVID-19 Patients
India-based Glenmark Pharmaceuticals says its antiviral favipiravir has shown promise as a COVID-19 treatment in mild to moderate patients.
Source: Devices & Diagnostics Letter
India-based Glenmark Pharmaceuticals says its antiviral favipiravir has shown promise as a COVID-19 treatment in mild to moderate patients.
Source: Devices & Diagnostics Letter